SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-008745
Filing Date
2024-02-01
Accepted
2024-02-01 08:33:19
Documents
16
Period of Report
2024-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192624-8k_enzobiochem.htm   iXBRL 8-K 36909
2 ENZO BIOCHEM, INC. PRESS RELEASE DATED FEBRUARY 1, 2024 ea192624ex99-1_enzobiochem.htm EX-99.1 9031
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8976
  Complete submission text file 0001213900-24-008745.txt   235198

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20240131.xsd EX-101.SCH 3000
5 XBRL LABEL FILE enz-20240131_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE enz-20240131_pre.xml EX-101.PRE 22350
17 EXTRACTED XBRL INSTANCE DOCUMENT ea192624-8k_enzobiochem_htm.xml XML 3497
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 24585138
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)